Plus Therapeutics reported $8.15M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
Baxter International USD 2.68B 3.36B Jun/2026
Cerus USD 34.78M 2.98M Dec/2024
Dr.Reddys Laboratories INR 77.75B 3.17B Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
Northwest Biotherapeutics USD 11.39M 120.04M Mar/2026
Plus Therapeutics USD 8.15M 1.04M Mar/2026
Sanofi EUR 9.92B 607M Jun/2026
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Sun Pharmaceuticals INR 117.43B 648.5M Jun/2026
Teva Pharmaceutical Industries USD 3.92B 691M Jun/2026